155 related articles for article (PubMed ID: 35695657)
1. Exploring Liposomes for Lung Cancer Therapy.
Shahid A; Khan MM; Ahmad U; Haider MF; Ali A
Crit Rev Ther Drug Carrier Syst; 2022; 39(4):1-47. PubMed ID: 35695657
[TBL] [Abstract][Full Text] [Related]
2. Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications.
Rudokas M; Najlah M; Alhnan MA; Elhissi A
Med Princ Pract; 2016; 25 Suppl 2(Suppl 2):60-72. PubMed ID: 26938856
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. Multi-functional vesicles for cancer therapy: The ultimate magic bullet.
Tavano L; Muzzalupo R
Colloids Surf B Biointerfaces; 2016 Nov; 147():161-171. PubMed ID: 27500359
[TBL] [Abstract][Full Text] [Related]
5. Emerging trends in the novel drug delivery approaches for the treatment of lung cancer.
Sharma P; Mehta M; Dhanjal DS; Kaur S; Gupta G; Singh H; Thangavelu L; Rajeshkumar S; Tambuwala M; Bakshi HA; Chellappan DK; Dua K; Satija S
Chem Biol Interact; 2019 Aug; 309():108720. PubMed ID: 31226287
[TBL] [Abstract][Full Text] [Related]
6. Stimuli-responsive Smart Liposomes in Cancer Targeting.
Jain A; Jain SK
Curr Drug Targets; 2018 Feb; 19(3):259-270. PubMed ID: 26853324
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of transferrin-conjugated liposomes to an orthotopic model of lung cancer in nude rats.
Gaspar MM; Radomska A; Gobbo OL; Bakowsky U; Radomski MW; Ehrhardt C
J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25(6):310-8. PubMed ID: 22857016
[TBL] [Abstract][Full Text] [Related]
8. Updates on the use of liposomes for active tumor targeting in cancer therapy.
Yan W; Leung SS; To KK
Nanomedicine (Lond); 2020 Feb; 15(3):303-318. PubMed ID: 31802702
[TBL] [Abstract][Full Text] [Related]
9. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
Yu HP; Aljuffali IA; Fang JY
Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
[TBL] [Abstract][Full Text] [Related]
10. Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer.
Patel K; Doddapaneni R; Sekar V; Chowdhury N; Singh M
Mol Pharm; 2016 Jun; 13(6):2049-58. PubMed ID: 27070720
[TBL] [Abstract][Full Text] [Related]
11. Liposomes in Active, Passive and Acoustically-Triggered Drug Delivery.
Basha SA; Salkho N; Dalibalta S; Husseini GA
Mini Rev Med Chem; 2019; 19(12):961-969. PubMed ID: 30961495
[TBL] [Abstract][Full Text] [Related]
12. Investigating the Application of Liposomes as Drug Delivery Systems for the Diagnosis and Treatment of Cancer.
Allahou LW; Madani SY; Seifalian A
Int J Biomater; 2021; 2021():3041969. PubMed ID: 34512761
[TBL] [Abstract][Full Text] [Related]
13. Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy.
Soe ZC; Thapa RK; Ou W; Gautam M; Nguyen HT; Jin SG; Ku SK; Oh KT; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2018 Oct; 170():718-728. PubMed ID: 30005409
[TBL] [Abstract][Full Text] [Related]
14. Nanocarrier-Mediated Drug Delivery via Inhalational Route for Lung Cancer Therapy: A Systematic and Updated Review.
Ara N; Hafeez A
AAPS PharmSciTech; 2024 Feb; 25(3):47. PubMed ID: 38424367
[TBL] [Abstract][Full Text] [Related]
15. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response.
Jiang L; Li L; He X; Yi Q; He B; Cao J; Pan W; Gu Z
Biomaterials; 2015 Jun; 52():126-39. PubMed ID: 25818419
[TBL] [Abstract][Full Text] [Related]
16. [Liposomes--therapeutic progress and technological problems].
Szulc J; Dudzik M; Woyczikowski B; Sznitowska M; Janicki S
Pol Merkur Lekarski; 2002 Feb; 12(68):164-8. PubMed ID: 11995258
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin loaded liposomes for lung tumor targeting: in vivo cell line study in human lung cancer.
Guo Y; Zhu Q; Shi J; Li Y; Fu D; Qiao D; Chen S; Yang Y; Wang Y
J BUON; 2020; 25(3):1504-1511. PubMed ID: 32862597
[TBL] [Abstract][Full Text] [Related]
18. Liposomal drug delivery systems for targeted cancer therapy: is active targeting the best choice?
Fathi S; Oyelere AK
Future Med Chem; 2016 Nov; 8(17):2091-2112. PubMed ID: 27774793
[TBL] [Abstract][Full Text] [Related]
19. Microfluidic Assembly of Liposomes with Tunable Size and Coloading Capabilities.
Hoffman JR; Tasciotti E; Molinaro R
Methods Mol Biol; 2018; 1792():205-214. PubMed ID: 29797262
[TBL] [Abstract][Full Text] [Related]
20. Liposomes, new carriers for delivery of genes and anticancer drugs: a systematic review.
Salari N; Rasoulpoor S; Valipour E; Mansouri K; Bartina Y; Dokaneheifard S; Mohammadi M; Abam F
Anticancer Drugs; 2022 Jan; 33(1):e9-e20. PubMed ID: 34282743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
